Percutaneous Coronary Intervention
📧 Sign up to get email alerts when something new happens for Percutaneous Coronary Intervention.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) [NA]
A completed Mayo Clinic trial (iCARE) evaluated mobile case management to improve cardiac rehabilitation outcomes.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) [NA]
Clinical trial results for iCARE trial evaluating mobile case management to improve cardiac rehabilitation outcomes in patients with acute m…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Different Doses of Colchicine on hsCRP [Phase 4]
Phase 4 trial evaluating different doses of colchicine on hsCRP in patients with coronary artery disease undergoing percutaneous coronary in…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Residual Inflammatory Risk-Guided colcHicine in Elderly Trial [Phase 4]
A Phase 4 clinical trial update exploring residual inflammatory risk-guided colchicine in elderly patients undergoing percutaneous coronary …
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI [Phase 2]
Phase 2 study evaluating safety and efficacy of PRT060128, a P2Y12 inhibitor, in non-urgent PCI; trial completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI [Phase 4]
A Phase 4 clinical trial is evaluating dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome a…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: GRX With ReMOTE: First in Human in India [NA]
First-in-human clinical trial update for GRX with ReMOTE in India; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 [Phase 2]
Phase 2 trial updating clopidogrel escalation using a genetic strategy in myocardial infarction patients undergoing percutaneous coronary in…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel [Phase 2]
Phase 2 trial update on the efficacy, safety, and pharmacokinetics of vicagrel as an antiplatelet therapy in coronary artery disease patient…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. [Phase 4]
Phase 4 clinical trial evaluating bivalirudin in elderly patients undergoing elective percutaneous coronary intervention; current status unk…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction [Phase 4]
Phase 4 clinical trial update on bivalirudin in elderly patients with STEMI undergoing percutaneous coronary intervention.
-
CLINICAL_TRIALS trial_result · 2018-10-05Clinical Trial Update: A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk [Phase 2, Phase 3]
A pharmacodynamic study comparing a personalized P2Y12 inhibition strategy against ticagrelor to reduce ischemic and bleeding risk in acute …
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention [Phase 3]
Phase 3 trial evaluating two rivaroxaban strategies versus oral vitamin K antagonist in patients with atrial fibrillation undergoing percuta…